Norbert Schmitz

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

Leukemia

Investigational new drugs

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Oertel, Marita Ziepert, Fabian Frontzek, Nina Nacke, Bettina Altmann, Maike Nickelsen, Bertram Glass, Viola Poeschel, Christian Ruebe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial. Leukemia 38 (5) (2024)
Olivier Tournilhac, Bettina Altmann, Birte Friedrichs, Kamal Bouabdallah, Mathieu Leclerc, Guillaume Cartron, Pascal Turlure, Peter Reimer, Eva Maria Wagner-Drouet, Laurence Sanhes, Houot Roch, Murielle Roussel, Frank Kroschinsky, Peter Dreger, Andreas Viardot, Laurence L de Leval, Andreas Rosenwald, Philippe Gaulard, Gerald Georg Wulf, Alban Villate, Christelle Latiere, Ahmet Elmaagacli, Bertram Glass, Viola Poeschel, Gandhi Laurent Damaj, David Sibon, Eric Durot, Karin Bilger, Anne Banos, Mathias Haenel, Martin Dreyling, Ulrich Bernd Keller, Mourad Tiab, Bernard Drénou, Jérome Cornillon, Stéphanie Nguyen, Marie Robin, Maike Nickelsen, Lorenz Trümper, Georg Lenz, Marita Ziepert, Norbert Schmitz, null null, null null, null null, null null
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Michael Oertel, Marita Ziepert, Fabian Frontzek, Nina Nacke, Bettina Altmann, Maike Nickelsen, Bertram Glass, Viola Poeschel, Christian Ruebe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial. Leukemia 38 (5) (2024)
Michael Oertel, Marita Ziepert, Fabian Frontzek, Nina Nacke, Bettina Altmann, Maike Nickelsen, Bertram Glass, Viola Poeschel, Christian Ruebe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial. Leukemia 38 (5) (2024)
Michael Oertel, Marita Ziepert, Fabian Frontzek, Nina Nacke, Bettina Altmann, Maike Nickelsen, Bertram Glass, Viola Poeschel, Christian Ruebe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial. Leukemia (2024)
Michael Oertel, Marita Ziepert, Fabian Frontzek, Nina Nacke, Bettina Altmann, Maike Nickelsen, Bertram Glass, Viola Poeschel, Christian Ruebe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial. Leukemia 38 (5) (2024)
Fabian Frontzek, Richard Greil, Ulrich Dührsen, Viola Poeschel, Sophie Bernard, Loïc Chartier, Nicolas Ketterer, Christian Récher, Olivier Fitoussi, Gerhard Held, René-Olivier Casasnovas, Corinne Haioun, Nicolas Mounier, Hervé Tilly, Judith Trotman, Steven Le Gouill, Imke E Karsten, Gerben Duns, Christian Steidl, David W Scott, Wolfram Klapper, Andreas Rosenwald, German Ott, Thierry Molina, Georg Lenz, Marita Ziepert, Bettina Altmann, Catherine Thieblemont, Norbert Schmitz
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaboration. Leukemia (2024)
Philipp Berning, Norbert Schmitz, Maud Ngoya, Hervé Finel, Ariane Boumendil, Fengrong Wang, Xiao-Jun Huang, Olivier Hermine, Laure Philippe, Lucile Couronné, Arnaud Jaccard, Dai-Hong Liu, Depei Wu, Hans Christian Reinhardt, Yves Chalandon, Eva Maria Wagner-Drouet, Mi Kwon, Xi Zhang, Ben Carpenter, Ibrahim Yakoub Agha, Gerald Wulf, Javier López-Jiménez, Jaime Sanz, Hélène Labussière-Wallet, Avichai Shimoni, Peter Dreger, Anna Sureda, Won Seog Kim, Bertram Glass
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis. Leukemia (2023)
Philipp Berning, Norbert Schmitz, Maud Ngoya, Hervé Finel, Ariane Boumendil, Fengrong Wang, Xiao-Jun Huang, Olivier Hermine, Laure Philippe, Lucile Couronné, Arnaud Jaccard, Dai-Hong Liu, Depei Wu, Hans Christian Reinhardt, Yves Chalandon, Eva Maria Wagner-Drouet, Mi Kwon, Xi Zhang, Ben Carpenter, Ibrahim Yakoub Agha, Gerald Wulf, Javier López-Jiménez, Jaime Sanz, Hélène Labussière-Wallet, Avichai Shimoni, Peter Dreger, Anna Sureda, Won Seog Kim, Bertram Glass
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis. Leukemia (2023)
Frank Kroschinsky, Jan Moritz Middeke, Martin Janz, Georg Lenz, Mathias Witzens-Harig, Reda Bouabdallah, Paul La Rosée, Andreas Viardot, Gilles Salles, Seok Jin Kim, Tae Min Kim, Oliver Ottmann, Joerg Chromik, Anne-Marie Quinson, Ute von Wangenheim, Ute Burkard, Andreas Berk, Norbert Schmitz
Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B cell non-Hodgkin lymphoma. Investigational new drugs (2020)
Frank Kroschinsky, Jan Moritz Middeke, Martin Janz, Georg Lenz, Mathias Witzens-Harig, Reda Bouabdallah, Paul La Rosée, Andreas Viardot, Gilles Salles, Seok Jin Kim, Tae Min Kim, Oliver Ottmann, Joerg Chromik, Anne-Marie Quinson, Ute von Wangenheim, Ute Burkard, Andreas Berk, Norbert Schmitz
Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Investigational new drugs 38 (5) (2020)
Frank Kroschinsky, Jan Moritz Middeke, Martin Janz, Georg Lenz, Mathias Witzens-Harig, Reda Bouabdallah, Paul La Rosée, Andreas Viardot, Gilles Salles, Seok Jin Kim, Tae Min Kim, Oliver Ottmann, Joerg Chromik, Anne-Marie Quinson, Ute von Wangenheim, Ute Burkard, Andreas Berk, Norbert Schmitz
Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Investigational new drugs (2020)

Norbert Schmitz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Norbert Schmitz